2023-08-02 08:55:14 ET
- Adamis Pharmaceuticals Corporation ( NASDAQ: ADMP ) shares down 71% after it announced pricing of its public offering of 5,930,000 units at a price of $1.35 per unit.
- Each unit consists of one share of common stock and one warrant to purchase one share of common stock.
- The common warrants will be immediately exercisable at an exercise price of $1.35 per share and will expire five years from the date of issuance.
- Gross proceeds are expected to be about $8.0 million and the offering is expected to close on August 4.
- Source: Press Release
For further details see:
Adamis Pharmaceuticals down after announcing pricing of $8M public offering